The possible reasons may include the different exonic mutations that may impact different mechanisms, the breast cancer-specific effect of PIK3CA mutations (4), and the impact of treatment, which greatly varies subsequent to recurrence (17). This evidence concerns the gene PIK3CA and breast carcinoma.